NCT03682497 - Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Heart Failure

Interventions

DRUG

AZD9977

AZD9977 capsules taken orally for 28 days.

DRUG

Spironolactone

Spironolactone tablets taken orally for 28 days.

Trial Locations (18)

1309

Research Site, Sofia

1784

Research Site, Sofia

4002

Research Site, Plovdiv

250 01

Research Site, Brandýs nad Labem

470 77

Research Site, Česká Lípa

551 01

Research Site, Jaroměř

440 01

Research Site, Louny

530 02

Research Site, Pardubice

130 00

Research Site, Prague

140 59

Research Site, Prague

40-081

Research Site, Katowice

31-202

Research Site, Krakow

59-220

Research Site, Legnica

02-097

Research Site, Warsaw

50-981

Research Site, Wroclaw

HU3 2JZ

Research Site, Hull

LE3 9PQ

Research Site, Leicester

S5 7AU

Research Site, Sheffield